Psoriasis Drugs
Links shared publicly online about this topic
Putting Psoriasis Drugs To The Test
medicalnewstoday.com — “Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating” View full resource at medicalnewstoday.com
Most Recently Shared on January 15, 2010 at 1:12 pm By:
Psoriasis Drugs Tested
disabled-world.com — “Etanercept and ustekinumab drugs have proved effective in management of moderate to severe psoriasis” View full resource at disabled-world.com
Most Recently Shared on January 15, 2010 at 4:22 am By:
Psoriasis drugs put to the test
sciencedaily.com — “Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating patients with the condition.” View full resource at sciencedaily.com
Most Recently Shared on January 19, 2010 at 1:35 pm By:
Psoriasis Drugs Put to the Test http://www.sciencedaily.com/releases/2010/01/100113172138.htm
Cost of Psoriasis Drugs Rising Faster Than Others:
health.msn.com — “Cost of Psoriasis Drugs Rising Faster Than Others:” View full resource at health.msn.com
Most Recently Shared on January 18, 2010 at 9:43 pm By:
Cost of Psoriasis Drugs Rising Faster Than Others: http://bit.ly/8aNs2v
Abbott psoriasis drug succeeds in pivotal trial | Reuters
reuters.com — “NEW York (Reuters) - Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared with” View full resource at reuters.com
Most Recently Shared on October 12, 2010 at 3:08 pm By:
Abbott psoriasis drug succeeds in pivotal trial: NEW York (Reuters) - Abbott Laboratories' experimental psoriasis ... http://bit.ly/cpbFGm
Abbott psoriasis drug succeeds in pivotal trial
health.yahoo.net — “Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared with a commonly used medicine in a pivotal late-stage clinical trial, the company said on Monday.” View full resource at health.yahoo.net
Most Recently Shared on October 11, 2010 at 5:57 pm By:
Abbott psoriasis drug succeeds in pivotal trial: Abbott Laboratories' experimental psoriasis treatment briakinumab... http://bit.ly/91X2Mp
Abbott psoriasis drug succeeds in pivotal trial | Reuters
reuters.com — “NEW York (Reuters) - Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared with” View full resource at reuters.com
Most Recently Shared on October 11, 2010 at 4:30 pm By:
Abbott psoriasis drug succeeds in pivotal trial http://dlvr.it/6txmj
Abbott psoriasis drug succeeds in pivotal trial | Reuters
reuters.com — “NEW York (Reuters) - Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared with” View full resource at reuters.com
Most Recently Shared on October 11, 2010 at 8:45 pm By:
News: Abbott psoriasis drug briakinumab succeeds in pivotal trial http://reut.rs/dc3P5X - #health #pharma
No major heart risk seen in new psoriasis drugs
health.yahoo.net — “A new, highly effective class of psoriasis drugs did not appear to raise the risk of heart problems in a review of published studies, but the analysis may not have been big enough to detect rare cases, U.S. researchers said.” View full resource at health.yahoo.net
Most Recently Shared on August 23, 2011 at 9:15 pm By:
No major heart risk seen in new psoriasis drugs http://t.co/E8KyLSe
Psoriasis Drugs Not Linked To Increased Heart Risks: Study
huffingtonpost.com — “For people with severe cases of psoriasis, the injectable drugs known as biologics can provide much-needed relief from the itchy, flaky skin lesions caused by the disorder. These drugs are powerful, however, and they carry a small risk of potentially serious infections and other side effects. In addition, recent clinical trials have linked a newer subclass of biologics that includes the drugs ustekinumab (Stelara) and briakinumab to an increased risk of heart attack and stroke. Now, a new study ” View full resource at huffingtonpost.com
Most Recently Shared on August 24, 2011 at 11:03 pm By:
Psoriasis Drugs Not Linked To Increased Heart Risks: Study: For people with severe cases of psoriasis, the inje... http://t.co/ZTilLKz
Explosion in Psoriasis Drugs Development : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on February 7, 2011 at 10:31 pm By:
PSOresearch Explosion in #Psoriasis #Drugs Development. http://tinyurl.com/4hj7x5k
Psoriasis Drugs Show Promise - Science News
sciencenews.org — “Targeted medications effective at clearing skin condition” View full resource at sciencenews.org
Most Recently Shared on March 29, 2012 at 2:22 pm By:
Psoriasis drugs show promise: Targeted medications effective at clearing skin condition http://t.co/OqoBOZXK
Hurdle for Abbott's Psoriasis Drug - Yahoo! Finance
finance.yahoo.com — “In a filing with the US Securities and Exchange Commission (SEC), Abbott Laboratories (NYSE: ABT - News) recently announced the withdrawal of its marketing applications” View full resource at finance.yahoo.com
Most Recently Shared on January 17, 2011 at 8:07 pm By:
Hurdle for Abbott's Psoriasis Drug: Abbott withdrew its US as well as European marketing authorization applicati... http://bit.ly/ef7ISo
Positive Data on Lilly Psoriasis Drug - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Results from the study showed that ixekizumab achieved its primary endpoint.” View full resource at finance.yahoo.com
Most Recently Shared on April 3, 2012 at 2:37 am By:
Positive Data on Lilly Psoriasis Drug: Results from the study showed that ixekizumab achieved its primary endpoint. http://t.co/UrtW72qx
National Psoriasis Foundation - FDA approves new psoriasis drug
psoriasis.org — “National Psoriasis Foundation - FDA approves new psoriasis drug” View full resource at psoriasis.org
Most Recently Shared on September 25, 2009 at 10:21 pm By:
Correction: It's spelled Stelara. And you can read more about it here: http://bit.ly/7o7nK
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
-
Stephen Roberts, MD
-
hospital 2020
A mission to promote safety, innovation, sustainability and global interaction to transform hospitals .Join the Movement . Share the Vision !
Advertisement

